Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-07

FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved an original generic application for rizatriptan benzoate (Unichem Pharmaceuticals USA) for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)